Related references
Note: Only part of the references are listed.Structure and mechanism of the RNA polymerase II transcription machinery
Allison C. Schier et al.
GENES & DEVELOPMENT (2020)
Using Chemical Epigenetics to Target Cancer
Virangika K. Wimalasena et al.
MOLECULAR CELL (2020)
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello et al.
NATURE CANCER (2020)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
Matthew G. Oser et al.
GENES & DEVELOPMENT (2019)
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid et al.
NATURE GENETICS (2018)
The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells
M. Carmen Lafita-Navarro et al.
GENES & DEVELOPMENT (2018)
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
Adam D. Durbin et al.
NATURE GENETICS (2018)
The biological significance of histone modifiers in multiple myeloma: clinical applications
Hiroto Ohguchi et al.
BLOOD CANCER JOURNAL (2018)
ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data
Shinya Oki et al.
EMBO REPORTS (2018)
The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation
Ann-Sofie B. Brier et al.
NUCLEIC ACIDS RESEARCH (2017)
Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair
Fade Gong et al.
JOURNAL OF CELL BIOLOGY (2017)
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
T. Harada et al.
LEUKEMIA (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
JARID1 Histone Demethylases: Emerging Targets in Cancer
Kayla M. Harmeyer et al.
TRENDS IN CANCER (2017)
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Anthony Tumber et al.
CELL CHEMICAL BIOLOGY (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131
Radhika A. Varier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition
John Arne Dahl et al.
NATURE (2016)
Structural analysis of human KDM5B guides histone demethylase inhibitor development
Catrine Johansson et al.
NATURE CHEMICAL BIOLOGY (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
A positioned+1 nucleosome enhances promoter-proximal pausing
Silvia Jimeno-Gonzalez et al.
NUCLEIC ACIDS RESEARCH (2015)
The Histone Demethylase KDM5 Activates Gene Expression by Recognizing Chromatin Context through Its PHD Reader Motif
Xingyin Liu et al.
CELL REPORTS (2015)
Physical and Functional Interactions between the Histone H3K4 Demethylase KDM5A and the Nucleosome Remodeling and Deacetylase (NuRD) Complex
Gohei Nishibuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Genome-wide localization of small molecules
Lars Anders et al.
NATURE BIOTECHNOLOGY (2014)
Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis
Jian Cao et al.
CELL REPORTS (2014)
Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome
David A. Orlando et al.
CELL REPORTS (2014)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation
Shannon M. Lauberth et al.
CELL (2013)
Extended Self-Renewal and Accelerated Reprogramming in the Absence of Kdm5b
Benjamin L. Kidder et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Revisiting Global Gene Expression Analysis
Jakob Loven et al.
CELL (2012)
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Zuqin Nie et al.
CELL (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)
Ping-Pui Wong et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
dKDM5/LID regulates H3K4me3 dynamics at the transcription-start site (TSS) of actively transcribed developmental genes
Marta Lloret-Llinares et al.
NUCLEIC ACIDS RESEARCH (2012)
Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation
Michael L. Beshiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Analysis of the Human Endogenous Coregulator Complexome
Anna Malovannaya et al.
CELL (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock
Luciano DiTacchio et al.
SCIENCE (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
The H3K4 Demethylase Lid Associates with and Inhibits Histone Deacetylase Rpd3
Nara Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
Gang G. Wang et al.
NATURE (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif
Shengjiang Tu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb
Anne Gegonne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4
Michiel Vermeulen et al.
CELL (2007)
RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3
Jesper Christensen et al.
CELL (2007)
PLU-1 is an H3K4 dernethylase involved in transcriptional repression and breast cancer cell proliferation
Kenichi Yamane et al.
MOLECULAR CELL (2007)
The retinoblastoma binding protein RBP2 is an H3K4 demethylase
Robert J. Klose et al.
CELL (2007)
Global mapping of c-Myc binding sites and target gene networks in human B cells
Karen I. Zeller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Myc-binding-site recognition in the human genome is determined by chromatin context
Ernesto Guccione et al.
NATURE CELL BIOLOGY (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
Binding of pRB to the PHD protein RBP2 promotes cellular differentiation
EV Benevolenskaya et al.
MOLECULAR CELL (2005)
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
A Wilson et al.
GENES & DEVELOPMENT (2004)
Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription
SW Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
